Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for doctrine of equivalents
Can amending the description to summarize the prior art add matter to the patent application as filed? (T 0471/20) Can amending the description to summarize the prior art add matter to the patent application as filed? (T 0471/20) Reviewed by Dr Rose Hughes on Wednesday, January 05, 2022 Rating: 5
Never Too Late: if you missed The IPKat last week Never Too Late: if you missed The IPKat last week Reviewed by Anastasiia Kyrylenko on Sunday, November 08, 2020 Rating: 5
Eli Lilly v Fresenius Kabi: a decision far from equivalent to what has been decided before Eli Lilly v Fresenius Kabi: a decision far from equivalent to what has been decided before Reviewed by Annsley Merelle Ward on Tuesday, June 25, 2019 Rating: 5
Fordham 27 (Report 10): Patent Potpurri Fordham 27 (Report 10): Patent Potpurri Reviewed by Annsley Merelle Ward on Tuesday, April 30, 2019 Rating: 5
Applying the Actavis questions to numerical limitations: Regen Lab v Estar Applying the Actavis questions to numerical limitations: Regen Lab v Estar Reviewed by Dr Rose Hughes on Monday, February 04, 2019 Rating: 5
Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in Icescape v Ice-World Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in Icescape v Ice-World Reviewed by Dr Rose Hughes on Wednesday, October 24, 2018 Rating: 5
Decoding the Scope of Patent Protection: Singapore after Eli Lilly v. Actavis Decoding the Scope of Patent Protection: Singapore after Eli Lilly v. Actavis Reviewed by Neil Wilkof on Friday, May 11, 2018 Rating: 5
Regeneron v Kymab - Part II: Interpretation and Infringement Regeneron v Kymab - Part II: Interpretation and Infringement Reviewed by Dr Rose Hughes on Friday, April 06, 2018 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.